Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esaxerenone in hypertensive T2D patients with albuminuria
NCT02807974Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esaxerenone in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02807974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807974.